Search Results 2221-2230 of 20710 for TIA

  1. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

    ischemic attack, or arrhythmias within 3 months prior to screening. 13. Symptomatic carotid stenosis or transient ischemic attack or stroke within 60 days

  2. Neurology - Doctors - Mayo Clinic

    Areas of focus: Stroke, Brain aneurysm, Guillain Barre syndrome, Transient ischemic attack, Intracerebral hemorrhage, Subarachnoid hemo...rrhage ...

  3. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    ous malformations, Transient ischemic attack, Amaurosis fugax, Vascular dementia, Venous thrombosis, Intracranial hematoma, Intracerebral hemorrhage ...

  4. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    ous malformations, Transient ischemic attack, Amaurosis fugax, Vascular dementia, Venous thrombosis, Intracranial hematoma, Intracerebral hemorrhage ...

  5. Stroke - Doctors and departments - Mayo Clinic

    Neurologist. Rochester, MN. Areas of focus: Stroke, Guillain Barre syndrome, Brain aneurysm, Transient ischemic attack, Subarachnoid hemorrhage, Cerebrovascular ...

  6. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Arterial thrombosis, except transient ischemic attack; or; Venous thrombosis, except superficial thrombophlebitis; or; Pregnancy morbidity, based on the ...

  7. Stroke - Doctors and departments - Mayo Clinic

    Williams, M.D.. Neurologist. Jacksonville, FL. Areas of focus: Telestroke, Stroke, Transient ischemic attack, Subdural hematoma, Carotid artery disease ...

  8. Stroke - Doctors and departments - Mayo Clinic

    ... Transient ischemic attack, Aortic aneurysm, Thoracic aortic aneurysm, Abdominal aortic aneurysm, Peripheral artery disease, Lymphedema, Chylothorax, Deep ...

  9. Stroke - Doctors and departments - Mayo Clinic

    Rabinstein, M.D.. Neurologist. Rochester, MN. Areas of focus: Stroke, Transient ischemic attack, Headache, Subarachnoid hemorrhage, Guillain Barre syndrome ...

  10. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Patients with a history of stroke who have not experienced a stroke or transient ischemic attack in the past 2 years and have no residual neurologic ...